Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
CN Stock MarketDetailed Quotes
Medicalsystem Biotechnology (300439)
- 10.19
- 0.000.00%
Market Closed May 7 15:00 CST
3.92BMarket Cap58.90P/E (TTM)
10.22High10.08Low39.61KlotVolume10.19Open10.19Prev Close40.24MTurnover1.36%Turnover Ratio62.13P/E (Static)384.32MShares12.2052wk High1.31P/B2.98BFloat Cap9.0852wk Low12.23Limit Up292.33MShs Float77.79Historical High8.15Limit Down1.37%Range %7.01Historical Low0.14Dividend TTM10.16Avg Price21.30KlotAsk1.32%Div Yield TTM100Lot Size17.19KlotBid
Medicalsystem Biotechnology (300439) Balance Sheet
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 2.11%571.68M | -9.75%657.57M | 5.55%630.52M | -3.57%687.7M | -30.82%559.86M | -24.01%728.64M | -35.72%597.36M | -22.27%713.16M | 4.63%809.34M | 18.91%958.88M |
| Transactional financial assets | 15.90%255.76M | 64.78%265.43M | 4.12%265.9M | 3.73%195.23M | 214.34%220.67M | 2,584.69%161.08M | --255.38M | --188.21M | -12.30%70.2M | -92.52%6M |
| Notes receivable and accounts receivable | 7.26%609.3M | 5.09%581.39M | -1.70%574.79M | -7.06%540.63M | -1.64%568.04M | -2.55%553.26M | -14.21%584.73M | -15.48%581.67M | -21.22%577.48M | -30.45%567.72M |
| -Notes receivable | ---- | ---- | --0 | --1.16M | -63.32%1.39M | --237.05K | ---- | ---- | --3.8M | ---- |
| -Accounts receivable | 7.53%609.3M | 5.13%581.39M | -1.70%574.79M | -7.25%539.47M | -1.23%566.64M | -2.59%553.02M | -14.08%584.73M | -15.40%581.67M | -21.73%573.68M | -30.42%567.72M |
| Other receivables (including interest and dividends) | -22.93%11.73M | -30.04%10.88M | -35.28%12.45M | -34.77%12.83M | -47.31%15.21M | -57.18%15.56M | -66.28%19.24M | -70.14%19.68M | -65.24%28.87M | -52.01%36.32M |
| -Other receivable | ---- | -30.04%10.88M | ---- | -34.77%12.83M | ---- | -57.18%15.56M | ---- | -67.25%19.68M | ---- | -43.99%36.32M |
| Advance payment | -21.90%40.17M | 28.59%38.75M | 20.10%52.69M | 99.92%65.79M | 19.00%51.43M | -32.14%30.14M | -47.08%43.87M | -50.68%32.91M | -28.97%43.22M | -31.24%44.41M |
| Inventories | -7.63%250.58M | -19.21%231.07M | -2.94%254.35M | 4.03%258.88M | 15.55%271.27M | 10.42%286.01M | 18.11%262.04M | 19.50%248.85M | 11.42%234.76M | 18.79%259.01M |
| Receivable financing | --709.23K | -94.74%205.22K | -43.73%2.11M | --507.41K | ---- | 77.38%3.9M | 150.52%3.76M | ---- | --700K | 1,876.64%2.2M |
| Non-current assets due within one year | --64.07M | --61.79M | --53.97M | --53.57M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | 21.42%42.43M | -0.08%45.58M | 4.51%33.12M | 55.96%42.61M | 31.34%34.94M | 85.27%45.61M | 56.59%31.69M | 1,026.20%27.32M | 114.20%26.6M | 139.08%24.62M |
| Total current assets | 7.26%1.85B | 3.75%1.89B | 4.55%1.88B | 2.54%1.86B | -3.89%1.72B | -3.95%1.82B | -9.85%1.8B | -7.04%1.81B | -8.31%1.79B | -8.32%1.9B |
| Non Current assets | ||||||||||
| Other equity investment | 0.00%5M | 0.00%5M | 0.00%5M | 0.00%5M | 0.00%5M | 0.00%5M | -52.20%5M | -52.20%5M | -8.45%5M | -8.45%5M |
| Investment real estate | --166.34M | --167.47M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Long-term equity investment | -13.36%158.04M | -14.74%158.35M | -2.55%167.16M | 0.57%168.23M | 12.43%182.41M | 19.10%185.73M | 0.57%171.53M | 1.55%167.27M | 1.33%162.24M | -0.82%155.94M |
| Long term receivable account | --8.62M | --10.47M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Fixed assets | ---- | -14.89%1.15B | ---- | 34.88%1.34B | ---- | 37.63%1.35B | ---- | 25.40%990.2M | ---- | 18.19%981.58M |
| Constru in process | ---- | 73.62%20.82M | ---- | -93.87%15.29M | ---- | -92.53%11.99M | ---- | -8.52%249.52M | ---- | -15.44%160.5M |
| Intangible assets | -6.22%123.7M | -6.31%126.89M | 7.53%131.46M | 4.82%129.64M | 5.12%131.9M | 5.93%135.43M | 8.99%122.26M | 8.67%123.69M | 6.14%125.47M | 6.37%127.85M |
| Long deferred expense | -23.98%27.24M | -25.29%29.75M | 9.10%30.77M | 5.58%32.8M | 24.43%35.83M | 15.95%39.82M | 0.63%28.2M | 120.50%31.07M | 82.93%28.79M | 84.66%34.34M |
| Deferred tax assets | 12.52%55.48M | 29.49%52.77M | 41.41%61.76M | 23.41%52.54M | 35.50%49.3M | 14.69%40.75M | 46.57%43.67M | 27.61%42.57M | 26.09%36.39M | 39.05%35.53M |
| Usufruct assets | -30.20%36.89M | -26.06%39.39M | 19.16%46M | 56.76%47.57M | 65.49%52.85M | 47.11%53.28M | 19.58%38.61M | -17.93%30.34M | -24.32%31.94M | -19.40%36.22M |
| Other non current assets | -99.42%358.61K | -99.58%242.34K | -90.02%5.88M | -81.68%10.87M | 10.43%61.92M | 9.21%57.94M | 379.48%58.89M | 65.67%59.34M | 315.97%56.07M | 197.07%53.05M |
| Total non current assets | -6.37%1.75B | -6.37%1.76B | 0.58%1.78B | 5.80%1.8B | 13.19%1.87B | 18.30%1.88B | 12.63%1.77B | 8.08%1.7B | 8.53%1.65B | 5.15%1.59B |
| Total assets | 0.17%3.59B | -1.39%3.65B | 2.58%3.66B | 4.12%3.66B | 4.29%3.59B | 6.19%3.71B | 0.04%3.56B | -0.29%3.51B | -0.95%3.44B | -2.64%3.49B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | ---- | -33.38%20M | --0 | ---- | ---- | -40.02%30.02M | -75.00%30.02M | -75.00%30.02M | -79.31%30.02M | -77.01%50.05M |
| Notes payable and accounts payable | 4.93%329.59M | -3.52%356.41M | 14.76%359.42M | 1.10%344.17M | -1.79%314.1M | 10.78%369.41M | -8.37%313.21M | -9.32%340.43M | -7.88%319.81M | -10.90%333.46M |
| -Notes payable | -0.49%20.15M | 239.45%23.77M | --63.24M | 77.67%35.53M | -42.13%20.25M | -53.32%7M | ---- | -42.86%20M | 16.67%35M | -25.00%15M |
| -Accounts payable | 5.31%309.44M | -8.21%332.65M | -5.43%296.19M | -3.68%308.64M | 3.17%293.84M | 13.80%362.41M | -1.14%313.21M | -5.87%320.43M | -10.20%284.81M | -10.11%318.46M |
| Contract liabilities | -22.67%48.39M | -12.44%55.85M | 3.77%52.21M | 7.11%55.53M | 24.21%62.58M | -27.74%63.78M | -26.17%50.31M | -21.65%51.85M | -19.61%50.38M | 16.99%88.27M |
| Salaries payable | 10.62%44.84M | -19.13%73.93M | -14.49%65.92M | -16.02%54M | -11.82%40.54M | -7.54%91.41M | -22.43%77.09M | -3.65%64.3M | -2.58%45.97M | 2.79%98.87M |
| Taxs payable | -19.40%13.52M | -13.18%19.04M | -48.43%14.83M | 21.12%21.63M | -48.60%16.78M | -19.09%21.93M | -40.67%28.75M | -44.86%17.86M | -26.56%32.64M | -29.58%27.1M |
| Other payable (including interest and dividends) | 16.60%76.24M | 14.62%76.79M | 33.33%90.7M | 50.71%108.4M | -11.74%65.39M | -6.66%66.99M | -21.12%68.02M | -28.87%71.93M | -12.17%74.08M | -18.93%71.77M |
| -Dividend payable | ---- | ---- | ---- | --21.77M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other payable | ---- | 14.62%76.79M | ---- | 20.44%86.63M | ---- | -6.66%66.99M | ---- | -14.61%71.93M | ---- | -18.93%71.77M |
| Non current liabilities due within one year | -20.61%11.92M | -27.28%11.48M | 13.72%13.1M | 22.84%13.88M | -14.02%15.01M | -19.13%15.79M | -66.22%11.52M | -75.73%11.3M | -77.19%17.46M | -75.56%19.52M |
| Other current liabilities | 17.59%9.49M | 29.50%10.5M | 4.00%6.74M | 7.43%7.17M | 30.56%8.07M | -19.58%8.11M | -26.72%6.48M | -22.25%6.67M | -23.00%6.18M | 9.16%10.08M |
| Total current liabilities | 2.21%534.01M | -6.51%623.99M | 2.99%602.92M | 1.75%604.78M | -9.38%522.46M | -4.53%667.44M | -27.47%585.41M | -27.26%594.36M | -29.30%576.55M | -28.76%699.13M |
| Current liabilities | ||||||||||
| Estimate liabilities | -61.80%1.37M | -63.92%1.37M | --4.18M | --3.89M | --3.59M | 162.38%3.8M | ---- | ---- | ---- | -87.53%1.45M |
| Deferred tax liabilities | -39.22%25.52M | -41.65%27M | -28.29%40.55M | -26.71%40.68M | -10.95%41.99M | -4.43%46.28M | 36.54%56.54M | 43.47%55.51M | 12.79%47.16M | 38.43%48.42M |
| Long term deferred income | 24.53%25.76M | 52.55%25.96M | 67.21%27.17M | 124.37%26.94M | 93.81%20.68M | 71.94%17.02M | 327.09%16.25M | 212.48%12.01M | 367.35%10.67M | 326.48%9.9M |
| Lease liabilities | -26.99%26.25M | -25.24%27.74M | 29.88%31.94M | 90.74%33.75M | 82.53%35.96M | 57.28%37.11M | 24.05%24.59M | -18.90%17.69M | -19.20%19.7M | -12.51%23.6M |
| Total non current liabilities | -22.82%78.9M | -21.24%82.08M | 6.63%103.84M | 23.52%105.25M | 31.86%102.23M | 25.00%104.21M | 27.03%97.38M | 12.16%85.21M | -11.02%77.53M | 0.52%83.36M |
| Total liabilities | -1.89%612.91M | -8.50%706.06M | 3.51%706.76M | 4.48%710.03M | -4.49%624.69M | -1.39%771.65M | -22.74%682.79M | -23.90%679.57M | -27.54%654.08M | -26.47%782.49M |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.10%384.32M | 0.10%384.32M | 0.10%384.32M | 0.10%384.32M | 0.00%383.95M | 0.25%383.95M | 0.25%383.95M | 0.25%383.95M | 0.25%383.95M | 0.00%383M |
| Capital reserve funds | -0.10%1.12B | 0.07%1.12B | 0.43%1.12B | 0.56%1.12B | 0.53%1.12B | 0.99%1.12B | 0.27%1.12B | 0.03%1.12B | -0.10%1.12B | -0.67%1.11B |
| Surplus reserve funds | 0.00%134.59M | 0.00%134.59M | 11.07%134.59M | 11.07%134.59M | 11.07%134.59M | 11.07%134.59M | 0.00%121.18M | 0.00%121.18M | 0.00%121.18M | 0.00%121.18M |
| Retained profit | 1.09%1.37B | 0.86%1.34B | 2.22%1.33B | 5.66%1.33B | 11.94%1.35B | 17.08%1.32B | 18.12%1.3B | 19.95%1.26B | 22.78%1.21B | 23.72%1.13B |
| Less:Treasury stock | -50.00%2.91M | -50.00%2.91M | -50.71%2.91M | -50.71%2.91M | -1.43%5.82M | --5.82M | --5.91M | --5.91M | --5.91M | ---- |
| Other composite income | 1.41%-17.58M | -5.99%-17.95M | 50.89%-15.9M | 51.57%-15.88M | 38.76%-17.83M | 41.87%-16.94M | -30.07%-32.38M | -31.75%-32.78M | -18.79%-29.11M | -18.03%-29.14M |
| Shareholders equity without minority interests | 0.58%2.99B | 0.49%2.95B | 2.32%2.96B | 3.91%2.95B | 6.26%2.97B | 8.28%2.94B | 7.06%2.89B | 7.43%2.84B | 8.28%2.8B | 8.16%2.71B |
| Minority interests | 11.16%-6.44M | -3.47%-6.58M | 13.46%-7.3M | 30.51%-6.87M | 21.98%-7.25M | 22.82%-6.36M | 58.65%-8.43M | 40.27%-9.88M | 17.54%-9.29M | -187.88%-8.24M |
| Total shareholder equity | 0.60%2.98B | 0.48%2.95B | 2.36%2.95B | 4.03%2.95B | 6.36%2.96B | 8.38%2.93B | 7.56%2.88B | 7.73%2.83B | 8.39%2.79B | 7.43%2.71B |
| Total liabilityies and equity | 0.17%3.59B | -1.39%3.65B | 2.58%3.66B | 4.12%3.66B | 4.29%3.59B | 6.19%3.71B | 0.04%3.56B | -0.29%3.51B | -0.95%3.44B | -2.64%3.49B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm